Literature DB >> 15135601

Histo-blood group type change of the graft from B to O after ABO mismatched heart transplantation.

Simon C Koestner1, Andreas Kappeler, Thomas Schaffner, Thierry P Carrel, Urs E Nydegger, Paul Mohacsi.   

Abstract

A patient with blood group type O accidentally received a blood group B cardiac allograft. He died almost 5 years after transplantation because of transplant vasculopathy. We monitored the expression of ABO-type antigens on the vascular endothelial cells of the cardiac allograft for 44 months, using monoclonal antibodies for immunohistology. The antigenic profile of the graft endothelial cells changed progressively from B to O. This change was first detectable 14 months after transplantation and it was most prominent at the end of the observation period. Thus, we have shown that the allograft blood type of the endothelium of this patient's heart began to change from type B to his own, 1 year after transplantation. By 44 months post-transplantation, it had changed to O type.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15135601     DOI: 10.1016/S0140-6736(04)16179-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

1.  Endothelial colony-forming cells show a mature transcriptional response to shear stress.

Authors:  Anastasia D Egorova; Marco C DeRuiter; Hetty C de Boer; Simone van de Pas; Adriana C Gittenberger-de Groot; Anton J van Zonneveld; Robert E Poelmann; Beerend P Hierck
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-11-20       Impact factor: 2.416

Review 2.  Immunogenicity and allogenicity: a challenge of stem cell therapy.

Authors:  Dominique Charron; Caroline Suberbielle-Boissel; Reem Al-Daccak
Journal:  J Cardiovasc Transl Res       Date:  2008-09-26       Impact factor: 4.132

3.  Blood Group A antigen expression on cardiac endothelium is highly individualized: possible implications for transplantation.

Authors:  Eric A Gehrie; Justin M Cates; Hui Nian; Sandy J Olson; Pampee P Young
Journal:  Cardiovasc Pathol       Date:  2013-01-04       Impact factor: 2.185

Review 4.  Current Perspectives in ABO-Incompatible Kidney Transplant.

Authors:  Federica Maritati; Claudia Bini; Vania Cuna; Francesco Tondolo; Sarah Lerario; Valeria Grandinetti; Marco Busutti; Valeria Corradetti; Gaetano La Manna; Giorgia Comai
Journal:  J Inflamm Res       Date:  2022-05-25

Review 5.  Strategies to overcome the ABO barrier in kidney transplantation.

Authors:  Georg A Böhmig; Andreas M Farkas; Farsad Eskandary; Thomas Wekerle
Journal:  Nat Rev Nephrol       Date:  2015-09-01       Impact factor: 28.314

6.  Antibody-mediated rejection: pathogenesis, prevention, treatment, and outcomes.

Authors:  Olivia R Blume; Sarah E Yost; Bruce Kaplan
Journal:  J Transplant       Date:  2012-03-24

7.  Association between ABO Blood Group and Risk of Congenital Heart Disease: A 6-year large cohort study.

Authors:  Bailing Zu; Guoling You; Qihua Fu; Jing Wang
Journal:  Sci Rep       Date:  2017-02-17       Impact factor: 4.379

8.  Tailored total lymphoid irradiation in heart transplant patients: 10-years experience of one center.

Authors:  Pirus Ghadjar; Daniela Joos; Michele Martinelli; Roger Hullin; Marcel Zwahlen; Kristina Lössl; Thierry Carrel; Daniel M Aebersold; Paul Mohacsi
Journal:  Radiat Oncol       Date:  2010-01-16       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.